Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Pulse Biosciences (PLSE) Accumulated Depreciation & Amortization (2020 - 2025)

Historic Accumulated Depreciation & Amortization for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $4.3 million.

  • Pulse Biosciences' Accumulated Depreciation & Amortization rose 1067.74% to $4.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 1067.74%. This contributed to the annual value of $4.0 million for FY2024, which is 1415.42% up from last year.
  • Pulse Biosciences' Accumulated Depreciation & Amortization amounted to $4.3 million in Q3 2025, which was up 1067.74% from $4.2 million recorded in Q2 2025.
  • In the past 5 years, Pulse Biosciences' Accumulated Depreciation & Amortization registered a high of $4.3 million during Q3 2025, and its lowest value of $2.0 million during Q1 2021.
  • In the last 5 years, Pulse Biosciences' Accumulated Depreciation & Amortization had a median value of $3.3 million in 2021 and averaged $3.3 million.
  • Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 7379.96% in 2021, then plummeted by 1132.13% in 2022.
  • Pulse Biosciences' Accumulated Depreciation & Amortization (Quarter) stood at $3.3 million in 2021, then dropped by 11.32% to $3.0 million in 2022, then rose by 17.71% to $3.5 million in 2023, then grew by 14.15% to $4.0 million in 2024, then increased by 7.89% to $4.3 million in 2025.
  • Its last three reported values are $4.3 million in Q3 2025, $4.2 million for Q2 2025, and $4.1 million during Q1 2025.